© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Leah Lawrence
Articles
Subcutaneous Rituximab Maintained Efficacy, Was Safe in DLBCL, FL
October 09, 2019
Switching from intravenous to subcutaneous administration of rituximab for non-Hodgkin diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) resulted in similar efficacy with no new safety issues.
Optimal Treatment for Early-Stage Follicular Lymphoma Still Not Established
October 09, 2019
The international retrospective study included 365 patients with newly diagnosed early-stage follicular lymphoma rigorously staged with PET-CT and bone marrow biopsy.
Social Media Recruiting for Trials Falls Short
October 08, 2019
A survey of physicians found recruiting for trials through social media can be useful, but not for cancer therapeutic trials.
Potency of CAR T-Cell Therapy for Myeloma May Vary by Disease Stage
October 07, 2019
CAR T cells are a more effective therapy if manufactured for patients with multiple myeloma prior to the onset of relapsed or refractory disease.